Tue 10/05/2021 05:48 AM
Share this article:
German contract pharmaceutical manufacturer Aenova, which refinanced over the summer, missed its own sales and earnings expectations in July. Monthly sales came in at €58.5 million, falling short of both the group’s €64.3 million budget and the €68.6 million it generated the same month the prior year, sources told Reorg.

The top line drop impacted underlying EBITDA, which reached €9.6 million, missing the €11.2 million budgeted and down 20% on the €12
Share this article:
This article is an example of the content you may receive if you subscribe to a product of Reorg Research, Inc. or one of its affiliates (collectively, “Reorg”). The information contained herein should not be construed as legal, investment, accounting or other professional services advice on any subject. Reorg, its affiliates, officers, directors, partners and employees expressly disclaim all liability in respect to actions taken or not taken based on any or all the contents of this publication. Copyright © 2021 Reorg Research, Inc. All rights reserved.
Thank you for signing up
for Reorg on the Record!